An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Definitive Healthcare has announced the hiring of Carrie Lazorchak as its new Chief Revenue Officer. As part of her employment agreement, Lazorchak has been granted 385,695 time-based restricted stock units (RSUs) effective November 1, 2023. The RSUs will vest over a 4-year period, with 25% vesting on the 1-year anniversary of the grant date and the remainder vesting in quarterly installments over the subsequent 3 years.
Positive
None.
Negative
None.
FRAMINGHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of Carrie Lazorchak as Definitive Healthcare’s new Chief Revenue Officer, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted Ms. Lazorchak an inducement award consisting of 385,695 time-based restricted stock units (“RSUs”) effective November 1, 2023. This award was individually negotiated and was granted as an inducement material to Ms. Lazorchak’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
The award is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms and conditions of an applicable award agreement covering the grant. The RSUs will vest as follows, subject to Ms. Lazorchak’s continued employment through each such date: (i) 25% will vest on the 1-year anniversary of the date of grant; (ii) the remainder will vest in quarterly installments equal to 6.25% of the total RSUs over the subsequent 3 years, until fully vested.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.
Investor Contact: Brian Denyeau ICR for Definitive Healthcare brian.denyeau@icrinc.com 646-277-1251
Who is the new Chief Revenue Officer of Definitive Healthcare?
The new Chief Revenue Officer of Definitive Healthcare is Carrie Lazorchak.
What type of award did Carrie Lazorchak receive?
Carrie Lazorchak received 385,695 time-based restricted stock units (RSUs).
When will the RSUs vest?
The RSUs will vest over a 4-year period. 25% will vest on the 1-year anniversary of the grant date, and the remainder will vest in quarterly installments over the subsequent 3 years.
definitive healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. their product suite provides the most comprehensive and highest quality data available anywhere on over 8,100 hospitals and idns, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 acos and hies, 197,000 physician groups, 1.3 million physicians, and 750 canadian hospitals. the company’s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market. definitive healthcare is backed by spectrum equity. for more information or to trial the service, visit www.definitivehc.com.
